Lilly's head of diabetes and obesity Patrik Jonsson recently told Business Insider that orforglipron will likely unlock a much wider market, bringing the benefits of groundbreaking weight-loss drugs to people who can't, or don't want to, use injections
This approach allows the body to adjust to the medication while minimizing side effects
Siegel says some people may turn to microdosing to make a prescription last longer when paying out of pocket
Like its injectable counterpart, it also carries approval to reduce the risk of major adverse cardiovascular events (MACE), including cardiovascular death, heart attack, and stroke, in adults with established heart disease and obesity or overweight
It is always a huge letdown when they ask me if the patches work and I have to explain that there is no clinical evidence behind them
Guard Sleep and Manage Stress Sleep and stress hormones are often overlooked but powerful influences on hunger